Welcome to DukeHealth.org.
Skip over navigation
  • Home
  • Services
  • Locations
  • Physicians
  • Patient and Visitor Info
  • Clinical Trials
  • Event Calendar
  • Health Library
  • About Duke Medicine

Quick Links

  • Appointments
  • HealthView Patient Login
  • Quality and Safety
Home > Physicians > Leget, Gail A.
Jumbo Large Regular Text:
Print E-mail
Physicians

Gail A. Leget, MD

Related Content

Locations

  • Donayre Cancer Care Center

Services

  • Breast Cancer
  • Colorectal Cancer
  • Duke Center for Chronic Lymphocytic Leukemia
  • Esophageal Cancer
  • Esophageal Cancer Treatments
  • Gastrointestinal Cancer
  • Head and Neck Cancer
  • Hematologic Malignancies Program
  • Hematology Treatments
  • Leukemias, Lymphomas, and Myelomas
  • Lung Cancer
  • Prostate Cancer
  • Skin Cancer
  • Urologic Cancers

Share

Gail A. Leget, MD

Department / Division
Medicine / Medicine - Oncology

Address
711 North Franklin Street, Suite B
Whiteville, NC 28472

Appointment Telephone
910-641-8220

Office Telephone
910-641-8220

Fax Telephone
910-641-8226

Training
  • MD, Faculte Libre de Medecine, Lille (France), 1992

Residency
  • Internal Medicine, University of Virginia Affiliated Program, 1992-1995
  • Oncology, Roswell Park Cancer Institute, New York Hematology, Veterans Affairs Medical Center of Western New York, 1995-1998
  • Hematology/Oncology, State University of New York, Buffalo, 1995-1998

Clinical Interests
Lymphoma, incorporation of community/outpatient based clinical trials into the practice as well as various aspects of treating cancer in the geriatric population

Research Interests
Clinical Trials in the community, particularly involving the geriatric population.  It is becoming more important to get involved in clinical trials to obtain useful information for a community practice where the majority of cancer patients are seen and treated.  Major interests in lymphoma and treating late stage lung cancer.

Industry Relationships and Collaborations (What's this?)

This faculty member has no reported relationships with industry.

Representative Publications
Leget GA, Czuczman MS. Use of Ritaximab, the new FDA approved antibody. Curr Opin Oncol 10(6):548-51, 1998. (1998)

Contact Us | Careers | Privacy Policy | Make a Gift | Site Map | RSS Feeds | En Español | Mobile Site | Help
Duke Medicine | Duke School of Medicine | Duke Children's | Duke University
Toll-Free: 888-ASK-DUKE (888-275-3853)
Copyright © 2004-2012 Duke University Health System

About This Page

Updated: Nov. 24, 2008
Published: Dec. 12, 2006
URL: http://www.dukehealth.org/physicians/gail_a_leget